Study of Dyslipidemia in Patients with Systemic Lupus Erythematosus and its Correlation to Disease Activity

Serum Adiponectin Level in Patients with Systemic Lupus Erythematosus and its Correlation with Disease Activity

Serum Adiponectin and Insulin Resistance in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients

Lipid profile in systemic lupus erythematosus patients and its correlation with diseaseactivity parameters

GLUCOSE INTOLERANCE IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Insulin Resistance in Pediatric Systemic Lupus Erythematosus and Rheumatoid Arthritis

Insulin Resistance in Patients with Lupus Nephritis: Association to Cardiovascular Risk Factors, Disease Activity, and Subclinical Atherosclerosis

The Role of T-cell Immunoglobulin and Mucin Domain-Containing Molecule-3 as Disease Activity Marker in Systemic Lupus Erythematosus

Serum lipoxin A4 as a biomarker for systemic lupus erythematosus

Serum interleukin 29 in Rheumatoid Arthritis and Systemic Lupus Erythematosus patients and its association with disease activity.